Literature DB >> 14693018

Prevalence of skin diseases in Ibadan, Nigeria.

Adebola O Ogunbiyi1, Olaniyi O M Daramola, Olatunji O Alese.   

Abstract

AIM: To study the pattern of skin diseases in patients attending the skin clinic of the University College Hospital, Ibadan, Nigeria, and to compare our findings with studies performed earlier in the same clinic. PATIENTS AND METHODS: The study involved 1091 new patients who had attended the skin clinic of the University College Hospital, Ibadan, Nigeria, between January 1994 and December 1998. The patients were examined by the authors, and laboratory investigations were ordered when necessary to make a diagnosis.
RESULTS: An increased prevalence of eczema, idiopathic pruritus, urticaria, connective tissue diseases, and fixed drug eruptions was observed. Infections, such as scabies, candidiasis, and tinea versicolor, had also increased. Pyoderma, leprosy, onchocerciasis, and dermatophytoses showed a decline. Psoriasis was uncommon, although there was a slight increase in prevalence. Vitiligo and alopecia were stable. Cutaneous tuberculosis, such as lupus vulgaris, was rare.
CONCLUSIONS: Allergic conditions have increased; connective tissue disorders, such as systemic lupus erythematosus, scleroderma, and discoid lupus erythematosus, have also increased. Cutaneous disorders associated with human immunodeficiency virus infection, such as seborrheic dermatitis, have increased. Health workers need to be educated on the management and treatment of these conditions, and should be advised to refer patients to appropriate health facilities when necessary.

Entities:  

Mesh:

Year:  2004        PMID: 14693018     DOI: 10.1111/j.1365-4632.2004.01967.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  17 in total

1.  Skin diseases among children attending the out patient clinic of the University of Nigeria teaching hospital, Enug.

Authors:  L J Emodi; A N Ikefuna; U Uchendu; U A Duru
Journal:  Afr Health Sci       Date:  2010-12       Impact factor: 0.927

2.  The comparison of intelligence quotients of atopic and nonatopic children in ibadan, Nigeria.

Authors:  O O M Daramola; O O Ayoola; A O Ogunbiyi
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

Review 3.  Psoriatic arthritis in Africa.

Authors:  Ajesh B Maharaj; Adewale Adebajo
Journal:  Clin Rheumatol       Date:  2021-06-28       Impact factor: 2.980

4.  Prevalence of skin diseases in a dermatology outpatient clinic in Turkey. A cross-sectional, retrospective study.

Authors:  Memet Ersan Bilgili; Hamza Yildiz; Gulben Sarici
Journal:  J Dermatol Case Rep       Date:  2013-12-30

Review 5.  Spondyloarthritis in sub-Saharan Africa.

Authors:  Mohammed Tikly; Panganani Njobvu; Paul McGill
Journal:  Curr Rheumatol Rep       Date:  2014-06       Impact factor: 4.592

6.  The spectrum of skin diseases in a rural setting in Cameroon (sub-Saharan Africa).

Authors:  Anne-Cécile Zoung-Kanyi Bissek; Earnest Njih Tabah; Emmanuel Kouotou; Victor Sini; Faustin N Yepnjio; Rogers Nditanchou; Roland N Nchufor; Defo Defo; Fidèle Dema; Julius Y Fonsah; Alfred K Njamnshi; Walinjom F T Muna
Journal:  BMC Dermatol       Date:  2012-06-21

Review 7.  Acne keloidalis nuchae: prevalence, impact, and management challenges.

Authors:  Adebola Ogunbiyi
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-12-14

8.  Dermatologic conditions in teenage adolescents in Nigeria.

Authors:  Eshan B Henshaw; Olayinka A Olasode; Evelyn E Ogedegbe; Imaobong Etuk
Journal:  Adolesc Health Med Ther       Date:  2014-05-27

9.  Pattern of skin diseases at university of Benin teaching hospital, Benin city, Edo State, South-South Nigeria: a 12 month prospective study.

Authors:  Agwu Bob Ukonu; E U Eze
Journal:  Glob J Health Sci       Date:  2012-04-28

10.  The Prevalence of Vitiligo: A Meta-Analysis.

Authors:  Yuhui Zhang; Yunfei Cai; Meihui Shi; Shibin Jiang; Shaoshan Cui; Yan Wu; Xing-Hua Gao; Hong-Duo Chen
Journal:  PLoS One       Date:  2016-09-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.